Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;49(7):1207-1208.
doi: 10.1038/s41366-025-01788-4. Epub 2025 Apr 16.

Expanding applications of GLP-1 therapies: a careful view

Domenico Azzolino  1 , Tiziano Lucchi  2
Affiliations

Expanding applications of GLP-1 therapies: a careful view

Domenico Azzolino et al. Int J Obes (Lond). 2025 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, et al. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2025;13:15–28. - PubMed
    1. Jastreboff, Roux AM, le CW, Stefanski A, Aronne LJ, Halpern B, et al. Tirzepatide for obesity treatment and diabetes prevention. N Engl J Med. 2025;392:958–71. - PubMed
    1. Prado CM, Phillips SM, Gonzalez MC, Heymsfield SB. Muscle matters: the effects of medically induced weight loss on skeletal muscle. Lancet Diabetes Endocrinol. 2024;12:785–7. - PubMed
    1. Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, et al. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2025;26:e13841. - PubMed
    1. American Diabetes Association Professional Practice Committee. 13. Older adults: standards of care in diabetes—2025. Diabetes Care. 2024;48:S266–82.

LinkOut - more resources